AKEBIA THERAPEUTICS, INC. Inventory, Work in Process, Net of Reserves
AKEBIA THERAPEUTICS, INC. (AKBA) had Inventory, Work in Process, Net of Reserves of $2.64 million as of 2023-09-30, per its 10-Q filed 2023-11-08.
Discontinued › Notes › Inventory › Inventory, Finished Goods and Work in Process, Net of Reserves
us-gaap:InventoryWorkInProcessNetOfReserves · last filed 2023-11-08
- 2023-09-30: Inventory, Work in Process, Net of Reserves $2.64M.
- 2023-06-30: Inventory, Work in Process, Net of Reserves $8.57M.
- 2023-03-31: Inventory, Work in Process, Net of Reserves $8.10M.
- 2022-12-31: Inventory, Work in Process, Net of Reserves $7.89M; Inventory, Work in Process, Net of Reserves as first filed $8.09M.
| Period end | Inventory, Work in Process, Net of Reserves | Inventory, Work in Process, Net of Reserves as first filed |
|---|---|---|
| 2023-09-30 | $2.64M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $8.57M 10-Q · filed 2023-08-28 | |
| 2023-03-31 | $8.10M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $7.89M 10-Q · filed 2023-11-08 | $8.09M 10-K · filed 2023-03-10 |
| 2022-09-30 | $32.85M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $38.47M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $74.03M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $62.63M 10-K/A · filed 2023-08-28 | |
| 2021-09-30 | $76.86M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $78.29M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $65.00M 10-Q · filed 2021-05-10 | |
| 2020-12-31 | $64.08M 10-K · filed 2022-03-01 | |
| 2020-09-30 | $90.16M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $101.64M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $135.47M 10-Q · filed 2020-05-05 | |
| 2019-12-31 | $137.86M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $152.21M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $177.28M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $198.96M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $215.12M 10-K · filed 2020-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Greenwich LifeSciences, Inc. (GLSI) | United States | $0.267B | -15.02 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Mereo BioPharma Group plc (MREO) | $0.269B | -9.41 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |